Drug Database
Back to search

Finland· FI-REL-REL61501

Zavicefta

A ceftazidim und beta-lactamase-inhibitor product containing ceftazidime pentahydrate + avibactam sodium, registered in Finland by Orifarm Oy. The same ATC class is registered in 10 of our 19 countries.

ATC J01DD52

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedZaviceftaATCJ01DD52REGISTER NO.FI-REL-REL61501PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ceftazidime pentahydrate + avibactam sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ceftazidim und beta-lactamase-inhibitor is registered in 10 of 19 countries.

Countries holding a registration under ATC J01DD52 (ceftazidim und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose
Search ceftazidim und beta-lactamase-inhibitor products by name

Ceftazidim und beta-lactamase-inhibitor · ATC J01DD52

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ceftazidim und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ceftazidim und beta-lactamase-inhibitor · price per daily dose (6 g)

USD · FX 28 Sept 2026

  • CH Switzerland$407.92
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Ceftazidime pentahydrate + Avibactam sodium
Manufacturer
Orifarm Oy
Country
Finland (FI)
ATC code
J01DD52
ATC class
Ceftazidim und Beta-Lactamase-Inhibitor
Defined daily dose
6 g, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    166141
    10 x (2 g / 0.5 g)
    EUR 1386.65

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ceftazidim und beta-lactamase-inhibitor in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ceftazidim und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Zavicefta
  • Liechtenstein · Zavicefta
  • Norway · Zavicefta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/20e361f2-8a9d-4eea-b135-1d3c2df11e10
GET /v1/drugs/20e361f2-8a9d-4eea-b135-1d3c2df11e10?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "6",
  "form": "kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos",
  "route": "Laskimoon",
  "ddd_unit": "g",
  "strength": "2 g / 0.5 g",
  "atc_label": "keftatsidiimi ja beetalaktamaasin estäjä",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/16/1109/001",
  "fimea_rel_id": "REL61501",
  "authorised_at": "2023-03-30"
}
API referenceMCP serverPlans

See everything about ceftazidim und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console